Plasmodium immunotherapy

· CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Plasmodium immunotherapy, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Plasmodium Immunotherapy for Advanced Ovarian Cancer [Phase 2, Phase 3]